Health-RELATED quality of life from the MM-003 trial of pomalidomide plus LOW-Dose dexamethasone VERSUS HIGH-DOSE dexamethasone in relapsed and/or refractory multiple myeloma

Additional Metadata
Keywords	Multiple myeloma, Pomalidomide, Quality of life
Persistent URL	doi.org/10.3324/haematol.2014.112557, hdl.handle.net/1765/91846
Journal	Haematologica
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Song, K. W., Dimopoulos, M., Weisel, K., Moreau, P., Palumbo, A., Belch, A., Schey, S., Sonneveld, P., Sternas, L., Yu, X., Amatya, R., Monzini, M. S., Zaki, M., Jacques, C.& San Miguel, J. F. (2015). Health-RELATED quality of life from the MM-003 trial of pomalidomide plus LOW-Dose dexamethasone VERSUS HIGH-DOSE dexamethasone in relapsed and/or refractory multiple myeloma. Haematologica, 100(2), 63–67.https://doi.org/10.3324/haematol.2014.112557

Publication